These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37258253)

  • 1. Prognostic implications of the immunohistochemical expression of perilipin 1 and adipophilin in high-grade liposarcoma.
    Kawaguchi K; Kohashi K; Mori T; Yamamoto H; Iwasaki T; Kinoshita I; Susuki Y; Furukawa H; Endo M; Matsumoto Y; Nakashima Y; Oda Y
    J Clin Pathol; 2023 May; ():. PubMed ID: 37258253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Perilipin in Liposarcomas: PLIN1 Differentiates Round Cell Liposarcoma From Other Round Cell Sarcomas.
    Compton ML; Al-Rohil RN
    Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):152-157. PubMed ID: 32205741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
    Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
    Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Expression of Perilipin Family Proteins can be used as Diagnostic Markers of Liposarcoma and to Differentiate Subtypes.
    Zhang Q; Zhang P; Li B; Dang H; Jiang J; Meng L; Zhang H; Zhang Y; Wang X; Li Q; Wang Y; Liu C; Li F
    J Cancer; 2020; 11(14):4081-4090. PubMed ID: 32368290
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perilipin 1 Expression Differentiates Liposarcoma from Other Types of Soft Tissue Sarcoma.
    Straub BK; Witzel HR; Pawella LM; Renner M; Eiteneuer E; Hashani M; Schirmacher P; Roth W; Mechtersheimer G
    Am J Pathol; 2019 Aug; 189(8):1547-1558. PubMed ID: 31125552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retroperitoneal dedifferentiated liposarcomas: semi-quantitative assessment of the dedifferentiated component and prognosis].
    Volkov AY; Kozlov NA; Nered SN; Stilidi IS; Stroganova AM; Arkhiri PP; Antonova EY; Privezentsev SA
    Arkh Patol; 2020; 82(5):25-32. PubMed ID: 33054029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and histopathological review of dedifferentiated liposarcoma: a comprehensive study of 123 primary tumours.
    Mori T; Yamada Y; Kinoshita I; Kohashi K; Yamamoto H; Ito Y; Susuki Y; Kawaguchi K; Nakashima Y; Oda Y
    Histopathology; 2022 Feb; 80(3):538-557. PubMed ID: 34699612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposarcomas of the mediastinum.
    Suster DI; Suster S
    Mediastinum; 2020; 4():27. PubMed ID: 35118295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perilipin 1 is a highly specific marker for adipocytic differentiation in sarcomas with intermediate sensitivity.
    Westhoff CC; Mrozinski J; Riedel I; Heid HW; Moll R
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):225-232. PubMed ID: 27646609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
    Crago AM; Socci ND; DeCarolis P; O'Connor R; Taylor BS; Qin LX; Antonescu CR; Singer S
    Clin Cancer Res; 2012 Mar; 18(5):1334-40. PubMed ID: 22241790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Liposarcoma Patients in Modern ERA: Single-Center Experience.
    Demir M; Güven D; Aktaş BY; Güner G; Aktepe OH; Taban H; Karakaş Y; Kılıçkap S; Kars A; Türker A; Dizdar Ö
    South Asian J Cancer; 2022 Oct; 11(4):287-292. PubMed ID: 36756104
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
    Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
    Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NY-ESO-1 as a diagnostic and prognostic marker for myxoid liposarcoma.
    Jo U; Roh J; Song MJ; Cho KJ; Kim W; Song JS
    Am J Transl Res; 2022; 14(2):1268-1278. PubMed ID: 35273728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
    Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
    Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDIT3 Expression in Liposarcoma Development.
    Kåbjörn Gustafsson C; Engström K; Aman P
    Sarcoma; 2014; 2014():954671. PubMed ID: 24790523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of miRNA-155 as a powerful diagnostic marker for dedifferentiated liposarcoma.
    Boro A; Bauer D; Born W; Fuchs B
    Am J Cancer Res; 2016; 6(2):544-52. PubMed ID: 27186423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.
    Ishii T; Kohashi K; Iura K; Maekawa A; Bekki H; Yamada Y; Yamamoto H; Nabeshima K; Kawashima H; Iwamoto Y; Oda Y
    Tumour Biol; 2016 Apr; 37(4):4767-76. PubMed ID: 26518767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
    Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
    Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
    Wu YV; Okada T; DeCarolis P; Socci N; O'Connor R; Geha RC; Joy Somberg C; Antonescu C; Singer S
    Genes Chromosomes Cancer; 2012 Apr; 51(4):313-27. PubMed ID: 22170698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.